
Corteva Inc (CTVA) Stock Forecast & Price Target
Corteva Inc (CTVA) Analyst Ratings
Bulls say
Corteva management has reaffirmed their guidance for 2025 and expressed confidence in achieving the current consensus for 2026, indicating stability in operational expectations. The company's projections suggest a solid financial foundation, with revenues estimated at approximately $3.845 billion compared to the consensus of $3.823 billion. Additionally, the Sum of the Parts (SOTP) valuation points to a potential 12% upside in the next year, with Corteva shares trading at a multiple of 12.0x the estimated EBITDA for 2025.
Bears say
Corteva's impending spin-off of its seeds business in 2026 has raised concerns regarding reduced growth potential and margins in its crop protection segment, suggesting a weakening competitive position, particularly against key rival Bayer. Additionally, potential declines in crop prices due to overproduction and reduced demand from crucial markets, such as China, could further hinder Corteva’s financial performance. The company's shares are expected to remain stagnant as it navigates the transition until the spin-off is completed, leading to a negative outlook on its stock.
This aggregate rating is based on analysts' research of Corteva Inc and is not a guaranteed prediction by Public.com or investment advice.
Corteva Inc (CTVA) Analyst Forecast & Price Prediction
Start investing in Corteva Inc (CTVA)
Order type
Buy in
Order amount
Est. shares
0 shares